PML-RARA fusion oncoprotein drugs for Acute Myeloid Leukemia

2 tracked PML-RARA fusion oncoprotein drugs in the Acute Myeloid Leukemia race. The class explanation lives on the PML-RARA fusion oncoprotein page; the full indication pipeline across every mechanism is on the Acute Myeloid Leukemia page.

2 Phase 3

Head-to-head evidence: Arsenic trioxide (QTX-2101) vs Arsenic trioxide (SDK001)

The roster

← all PML-RARA fusion oncoprotein drugs